Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-14-034305)

Filing Details

Accession Number:: 0001181431-14-034305
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-10-15 16:52:55
Reporting Period:: 2014-10-13

Filing Date:: 2014-10-15
Accepted Time:: 2014-10-15 16:52:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1567514	Intra-Cellular Therapies Inc.	ITCI	Pharmaceutical Preparations (2834)	364742850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1585663	P. Lawrence Wennogle	C/O Intra-Cellular Therapies, Inc. 3960 Broadway New York NY 10032	Vice President, Drug Discovery	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-10-13	1,600	$15.00	111,156	No	4	S	Direct
Common Stock	Disposition	2014-10-15	2,004	$15.00	109,152	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2014.